NLT SPINE Secures Additional Funding Of $5.7 million

NLT SPINE, a developer of Minimally Invasive Spine Surgery (MISS) products, announced it has secured additional funding from existing investors, Accelmed and Peregrine Ventures. The investment of $5.7 million will be used to fuel the development of its PROW LIF line for the treatment of degenerative spinal conditions, as well as expand its presence in the US market. This recent round increased the company’s previous funding to a total of $14.5 million. View and share